Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon J Patton

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Clinical Chemistry|February 4, 2006
Benchmark for evaluating the quality of DNA sequencing: proposal from an international external quality assessment schemeSimon J Patton, Andrew J Wallace, Rob Elles
European Journal of Human Genetics : EJHG|February 15, 2020
Evaluation of current genetic testing reports in German-speaking countries with regard to secondary use and future electronic implementationTeja Falk Radke, Simon J Patton, Elisabeth Pantazoglou, et al.
Archives of Pathology & Laboratory Medicine|July 26, 2014
Conversion, correction, and International Scale standardization: results From a Multicenter External Quality Assessment Study for BCR-ABL1 testingMichael Griffiths, Simon J Patton, Alberto Grossi, et al.
Clinical Chemistry and Laboratory Medicine|February 26, 2022
The value proposition of integrative diagnostics for (early) detection of cancer. On behalf of the EFLM interdisciplinary Task and Finish Group "CNAPS/CTC for early detection of cancer"Matthias F Froelich, Ettore Capoluongo, Zsolt Kovacs, et al.
European Journal of Human Genetics : EJHG|June 13, 2019
Current practices for the genetic diagnosis of autoinflammatory diseases: results of a European Molecular Genetics Quality Network SurveyDorota Rowczenio, Yael Shinar, Isabella Ceccherini, et al.
British Journal of Clinical Pharmacology|September 4, 2025
Uptake of DPYD and UGT1A1 testing in Italy and adherence to pharmacogenetic guidelines: A 5-year perspective from an EQA providerRossana Roncato, Samantha Perfler, Diletta Pasin, et al.
The Journal of Molecular Diagnostics : JMD|March 25, 2020
External Quality Assessment Schemes for Biomarker Testing in Oncology: Comparison of Performance between Formalin-Fixed, Paraffin-Embedded-Tissue and Cell-Free Tumor DNA in PlasmaKaat Van Casteren, Cleo Keppens, Ed Schuuring, et al.
Prenatal Diagnosis|February 16, 2019
Ensuring high standards for the delivery of NIPT world-wide: Development of an international external quality assessment schemeZandra C Deans, Stephanie Allen, Lucy Jenkins, et al.
Virchows Archiv : an International Journal of Pathology|November 10, 2022
External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot schemeRiziero Esposito Abate, Melanie H Cheetham, Jennifer A Fairley, et al.
Virchows Archiv : an International Journal of Pathology|December 9, 2022
Correction to: External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot schemeRiziero Esposito Abate, Melanie H Cheetham, Jennifer A Fairley, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Clinical Chemistry|February 4, 2006
Benchmark for evaluating the quality of DNA sequencing: proposal from an international external quality assessment schemeSimon J Patton, Andrew J Wallace, Rob Elles
European Journal of Human Genetics : EJHG|February 15, 2020
Evaluation of current genetic testing reports in German-speaking countries with regard to secondary use and future electronic implementationTeja Falk Radke, Simon J Patton, Elisabeth Pantazoglou, et al.
Archives of Pathology & Laboratory Medicine|July 26, 2014
Conversion, correction, and International Scale standardization: results From a Multicenter External Quality Assessment Study for BCR-ABL1 testingMichael Griffiths, Simon J Patton, Alberto Grossi, et al.
Clinical Chemistry and Laboratory Medicine|February 26, 2022
The value proposition of integrative diagnostics for (early) detection of cancer. On behalf of the EFLM interdisciplinary Task and Finish Group "CNAPS/CTC for early detection of cancer"Matthias F Froelich, Ettore Capoluongo, Zsolt Kovacs, et al.
European Journal of Human Genetics : EJHG|June 13, 2019
Current practices for the genetic diagnosis of autoinflammatory diseases: results of a European Molecular Genetics Quality Network SurveyDorota Rowczenio, Yael Shinar, Isabella Ceccherini, et al.
British Journal of Clinical Pharmacology|September 4, 2025
Uptake of DPYD and UGT1A1 testing in Italy and adherence to pharmacogenetic guidelines: A 5-year perspective from an EQA providerRossana Roncato, Samantha Perfler, Diletta Pasin, et al.
The Journal of Molecular Diagnostics : JMD|March 25, 2020
External Quality Assessment Schemes for Biomarker Testing in Oncology: Comparison of Performance between Formalin-Fixed, Paraffin-Embedded-Tissue and Cell-Free Tumor DNA in PlasmaKaat Van Casteren, Cleo Keppens, Ed Schuuring, et al.
Prenatal Diagnosis|February 16, 2019
Ensuring high standards for the delivery of NIPT world-wide: Development of an international external quality assessment schemeZandra C Deans, Stephanie Allen, Lucy Jenkins, et al.
Virchows Archiv : an International Journal of Pathology|November 10, 2022
External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot schemeRiziero Esposito Abate, Melanie H Cheetham, Jennifer A Fairley, et al.
Virchows Archiv : an International Journal of Pathology|December 9, 2022
Correction to: External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot schemeRiziero Esposito Abate, Melanie H Cheetham, Jennifer A Fairley, et al.
Pageof 3